RETRACTED ARTICLE: ShRNA-mediated gene silencing of Heat shock protein 70 inhibits human colon cancer cell growth in vitro and in vivo

Haidong Cai,Shaojun Yin,Fang Ma,Fei Yu,Dan Li,Mingli Lv,Yingsheng Chen,Zhongwei Lv
DOI: https://doi.org/10.1007/s11010-011-0990-3
IF: 3.842
2011-01-01
Molecular and Cellular Biochemistry
Abstract:Heat shock protein (HSP)70 is over expressed in human colon cancer and plays an important role in the progression of this cancer. To observe the gene silencing mediated by the specific shRNA targeted against HSP70 and its effect on cell proliferation and cycle distribution in the human colon cancer cell line HT29, and its potential role in gene therapy for this cancer. Two shRNA plasmid vectors against HSP70 were constructed and transfected into HT29 cells with LipofectamineTM2000. The down-regulation of HSP70 expressions was detected by RT-PCR, western blotting, and immunofluorescence analysis. The cell proliferation inhibition was determined by MTT assay. The effect of these two HSP70 shRNAs on cell cycle distribution and apoptosis was examined by flow cytometry. After s.c. injection into athymic nu/nu mice, the tumor growth, vessel density, and proliferation of each group was also determined. These two shRNA vectors targeted against HSP70 efficiently suppressed the expression of HSP70 and its down stream genes, c-myc and cyclinD1. The expression inhibition rates were around 40–50% either at the mRNA or at the protein level. The shRNA-mediated gene silencing of HSP70 resulted in significant inhibition of cell growth both on the culture plates and in the soft agar. Moreover, the cancer cells showed significant G0/G1 arrest and increased apoptosis at 72 h post-transfection due to gene silencing. Vessel density was assessed by CD31 and cell growth by PCNA immunohistochemical analysis. These specific shRNAs targeted against HSP70 could have a gene-silencing effect. They could inhibit cell growth, increase apoptosis, and induce cell cycle arrest in HT29 cells. ShRNA interference against HSP70 is of potential value in gene therapy of colon cancer.
What problem does this paper attempt to address?